BLRX - BioLineRx Ltd.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 0.68

Open

$ 0.67

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.66 - $ 0.69

52 Week Range

$ 0.55 - $ 2.53

Volume

201,619

Average Volume

Market Cap

49.26M

Beta (5Y Monthly)

$ 1.40

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on BioL...
04/17/2024 17:35:07

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioLine Rx (NASDAQ:BLRX) with a Buy and maintains $21 price target.

BioLineRx Announces Poster Presentation On...
04/17/2024 11:02:12

BioLineRx Has Drawn-down The Second Tranch...
04/10/2024 11:14:19

BioLineRx Announces $6M Registered Direct ...
04/01/2024 13:02:55

BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX) ("BioLineRx" or the "Company"), a commercial stage biopharmaceutical ...

HC Wainwright & Co. Reiterates Buy on BioL...
03/26/2024 16:12:57

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioLine Rx (NASDAQ:BLRX) with a Buy and maintains $21 price target.

BioLine Rx Q4 EPS $(0.15) Beats $(0.22) Es...
03/26/2024 13:28:42

BioLine Rx (NASDAQ:BLRX) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.22) by...

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
03/26/2024 13:05:52

BioLineRx FY23 Total Revenues $4.8M, EPS $...
03/26/2024 11:02:32

Earnings Scheduled For March 26, 2024
03/26/2024 08:47:27

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

Earnings Preview For BioLine Rx
03/25/2024 15:02:32

BioLineRx Announces Notice of Allowance fo...
03/04/2024 12:08:04

HC Wainwright & Co. Reiterates Buy on BioL...
02/29/2024 20:36:19

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioLine Rx (NASDAQ:BLRX) with a Buy and maintains $21 price target.

Biolinerx Announced First Patient Dosed In...
02/28/2024 12:14:21

BioLineRx Discloses Acceptance Of Two Post...
02/16/2024 12:05:28

BioLineRx Says First Patient Has Been Dose...
12/21/2023 12:02:49

HC Wainwright & Co. Reiterates Buy on BioL...
11/20/2023 17:37:15

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioLine Rx (NASDAQ:BLRX) with a Buy and maintains $21 price target.

Earnings Scheduled For November 20, 2023
11/20/2023 12:11:31

Companies Reporting Before The Bell • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.05 ...

BioLine Rx Says Cash, Cash Equivalents And...
11/20/2023 12:03:57

BioLine Rx Q3 EPS $(0.01) May Not Be Compa...
11/20/2023 12:02:27

BioLine Rx (NASDAQ:BLRX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.21) by...

BioLine Rx Earnings Preview
11/17/2023 14:01:47